Pentraxin 3 as a new biomarker of peritoneal injury in peritoneal dialysis patients

Journal of Artificial Organs

Volumn 16, Issue 1, 2013, Pages 66-73

  Kanda, Reo ^a   Hamada, Chieko ^a   Kaneko, Kayo ^a   Nakano, Takanori ^a   Wakabayashi, Keiichi ^a   Io, Hiroaki ^a   Horikoshi, Satoshi ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

EPS; Inflammation; Pentraxin 3 (PTX3); Peritoneal dialysis; Peritoneal injury

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD31 ANTIGEN; GELATINASE A; INTERLEUKIN 6; PENTRAXIN 3;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE MARKER; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; HEMODIALYSIS PATIENT; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; KIDNEY FAILURE; MALE; MESOTHELIUM CELL; PERITONEAL BIOPSY; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PERITONEAL EFFLUENT; PERITONEAL FLUID; PERITONEAL INJURY; PERITONITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TREATMENT DURATION;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PERITONEAL CAVITY; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PERITONEUM; SERUM AMYLOID P-COMPONENT;

EID: 84875226241     PISSN: 14347229     EISSN: 16190904     Source Type: Journal    
DOI: 10.1007/s10047-012-0663-3     Document Type: Article

References (23)

1. Slingeneyer A, Canaud B, Mion C. Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: an epidemiological study. Nephron. 1983;33:133-8. (Pubitemid 13190901)
2. Davies SJ, Bryan J, Phillips L, Russell GI. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant. 1996;11:498-506. (Pubitemid 26092790)
3. Dobbie JW. Morphology of the peritoneum in CAPD. Blood Purif. 1989;7:74-85. (Pubitemid 19115540)
4. Pollock CA, Ibels LS, Eckstein RP, Graham JC, Caterson RJ, Mahony JF, Sheil AG. Peritoneal morphology on maintenance dialysis. Am J Nephrol. 1989;9:198-204. (Pubitemid 19168642)
5. Kawanishi H, Kawaguchi Y, Fukui H, Hara S, Imada A, Kubo H, Kin M, Nakamoto M, Ohira S, Shoji T. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis. 2004;44:729-37. (Pubitemid 39237618)
6. Yamagata K, Tomida C, Koyama A. Intraperitoneal hyaluronan production in stable continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 1999;19:131-7. (Pubitemid 30088063)
7. Kawanishi H, Fujimori A, Tsuchida K, Takemoto Y, Tomo T, Minakuchi J, Yamamoto T, Kim M, Numata A, Choh S, Naito H, Peritoneal Effluent Study Group Japan. Markers in peritoneal effluent for withdrawal from peritoneal dialysis: multicenter prospective study in Japan. Adv Perit Dial. 2005;21:134-8.
8. Hirahara I, Inoue M, Okuda K, Ando Y, Muto S, Kusano E. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis - a multicentre study in Japan. Nephrol Dial Transplant. 2007;22:560-7. (Pubitemid 46189902)
9. Yokoyama K, Yoshida H, Matsuo N, Maruyama Y, Kawamura Y, Yamamoto R, Hanaoka K, Ikeda M, Yamamoto H, Nakayama M, Kawaguchi Y, Hosoya T. Serum beta2microglobulin (beta2MG) level is a potential predictor for encapsulating peritoneal sclerosis (EPS) in peritoneal dialysis patients. Clin Nephrol. 2008;69:121-6. (Pubitemid 351227965)
10. Numata M, Nakayama M, Hosoya T, Hoff CM, Holmes CJ, Schalling M, Nordfors L, Lindholm B. Possible pathologic involvement of receptor for advanced glycation end products (RAGE) for development of encapsulating peritoneal sclerosis in Japanese CAPD patients. Clin Nephrol. 2004;62:455-60. (Pubitemid 39654584)
11. Nakamoto H. Encapsulating peritoneal sclerosis - a clinician's approach to diagnosis and medical treatment. Perit Dial Int. 2005;25:S30-8.
12. Breviario F, d'Aniello EM, Golay J, Peri G, Bottazzi B, Bairoch A, Saccone S, Marzella R, Predazzi V, Rocchi M. Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component. J Biol Chem. 1992;267:22190-7.
13. Lee GW, Lee TH, Vilcek J. TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentraxin family of acute phase proteins. J Immunol. 1993;150:1804-12. (Pubitemid 23129656)
14. Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol. 2005;23:337-66. (Pubitemid 40563173)
15. Iwata Y, Yoshizaki A, Ogawa F, Komura K, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Takehara K, Sato S. Increased serum pentraxin3 in patients with systemic sclerosis. J Rheumatol. 2009;36:976-83.
16. Inoue K, Sugiyama A, Reid PC, Ito Y, Miyauchi K, Mukai S, Sagara M, Miyamoto K, Satoh H, Kohno I, Kurata T, Ota H, Mantovani A, Hamakubo T, Daida H, Kodama T. Establishment of high sensitivity plasma assay for human pentraxin 3 as a marker for unstable angina pectoris. Arterioscler Thromb Vasc Biol. 2007;27:161-7. (Pubitemid 46360394)
17. Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, Moore HL, Nielsen MP. Peritoneal equilibration test. Perit Dial Bull. 1987;7:138-47. (Pubitemid 18014430)
18. He X, Han B, Bai X, Zhang Y, Cypel M, Mura M, Keshavjee S, Liu M. PTX3 as a potential biomarler of acute lung injury: supporting evidence from animal experimentation. Intensive Care Med. 2010;36:356-64.
19. Chenillot O, Henny J, Steinmetz J, Herbeth B, Wagner C, Siest G. High sensitivity C-reactive protein: biological variations and reference limits. Clin Chem Lab Med. 2000;38:1003-11.
20. Fujimoto N, Mouri N, Iwata K, Ohuchi E, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies. Clin Chim Acta. 1993;221:91-103. (Pubitemid 24022824)
21. Nishizono I, Iida S, Suzuki N, Kawada H, Murakami H, Ashihara Y, Okada M. Rapid and sensitive chemiluminescent enzyme immuno-assay for measuring tumor markers. Clin Chem. 1991;37:1639-44. (Pubitemid 21905231)
22. Honda K, Hamada C, Nakayama M, Miyazaki M, Sherif AM, Harada T, Hirano H, Peritoneal Biopsy Study Group of the Japanese Society for Peritoneal Dialysis. Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: a quantitative study of peritoneal membrane morphology. Clin J Am Soc Nephrol. 2008;3:720-8.
23. Shimaoka T, Hamada C, Kaneko K, Io H, Sekiguchi Y, Aruga S, Inuma J, Inami Y, Hotta Y, Horikoshi S, Kumasaka T, Tomino Y. Quantitative evaluation and assessment of peritoneal morphologic changes in peritoneal dialysis patients. Nephrol Dial Transplant. 2010;25:3379-85.